What does dia mean in the pharmaceutical industry?

What dia means in the pharmaceutical industry: Medical Information Association.

Drug information association

China Medical News Information Association (CNDIA) was established in August 1993, and it is the only national first-class trade association in the field of medicine and health in China with news, information research, communication, industry self-discipline, standardization and rights protection as its main functions.

The competent unit is the State Council State-owned Assets Supervision and Administration Commission, and the business guidance units mainly include China Food and Drug Administration (CFDA), Health Planning Commission, Ministry of Industry and Information Technology, and China Journalists Association.

China Medical News Information Association, formerly known as China Medical Newspaper Association, was officially renamed at the end of 20 14. The members of the association mainly come from pharmaceutical, food and cosmetic enterprises, as well as related public relations consulting enterprises and publicity and publishing units. Individual members are mainly composed of editors, journalists, managers and industry experts of mainstream media.

Since its establishment, under the correct guidance of the relevant ministries and commissions of the central government, the association has closely United with mainstream media, members and industry experts, organized and carried out a large number of colorful activities, which have produced good social impact and contributed to the development of China's pharmaceutical industry.

In the 1990s, in view of the unsatisfactory medical system and chaotic market, the Association organized the mainstream media to make unannounced visits to expose the problems and published many good medical news works with great social repercussions. The Association held the "First National 10 Pharmaceutical Joint Venture Selection" in time and held a grand award ceremony in the Great Hall of the People.

Organize 7 consecutive "National Medicine Good News Selection" and 6 "National Food and Drug Supervision Good News Selection" activities; Under the guidance of the former US Food and Drug Administration (SFDA), the classic anthology of drug regulatory development in New China was published in 2065 10.

The association actively provides professional services for its members. We have cooperated closely with Lilly, Johnson & Johnson, Boehringer Ingelheim, Hainan Kuaike, Fosun Pharma, Hengrui Pharma, Luye Pharmaceutical, Tasly Group and other units, and hosted the development forum of medical sci-tech periodicals, the seminar on clinical pathway application and the seminar on drug standard management measures.

Academic seminar on drug standard system construction and drug research and development, series of lectures on cosmetic quality and safety, salon, media forum on children's safe drug use, media training on medical device quality and safety, and the first "Made in China" medical innovation communication forum.